Literature DB >> 16501034

A human tetraploid pachytene spermatocyte as the possible origin of diploid sperm: a case report.

M Codina-Pascual1, J Navarro, J Egozcue, J Benet.   

Abstract

Diploid spermatozoa represent 0.2-0.3% of all spermatozoa in the normal population and cause 8.3% of diandric triploids. Errors in meiosis I and II are the most common mechanisms by which diploid spermatozoa are produced. Endoreduplication before meiosis has been suggested as a possible origin for tetraploid meiocytes, which might, in turn, produce diploid sperm. Synaptonemal complex (SC) spreads of a fertile man were immunolabelled (SCP3, MLH1 and CENP) and hybridized with subtelomere-specific multiplex fluorescent in situ hybridization (stM-FISH) assay for SCs identification. The unexpected finding of a tetraploid pachytene cell and the identification of all of its SCs demonstrate that synapsis and crossover events can occur in human tetraploid cells. Moreover, it indicates that diploid sperm may also originate from mitotic errors (endoreduplication) occurring before meiosis.

Entities:  

Mesh:

Year:  2006        PMID: 16501034     DOI: 10.1093/humrep/del040

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

1.  Chromosomal Evolution in Mole Voles Ellobius (Cricetidae, Rodentia): Bizarre Sex Chromosomes, Variable Autosomes and Meiosis.

Authors:  Sergey Matveevsky; Oxana Kolomiets; Alexey Bogdanov; Mikhayil Hakhverdyan; Irina Bakloushinskaya
Journal:  Genes (Basel)       Date:  2017-11-03       Impact factor: 4.096

2.  True polyploid meiosis in the human male.

Authors:  Peter L Pearson; Kamlesh Madan
Journal:  Genet Mol Biol       Date:  2018-05-21       Impact factor: 1.771

3.  Meiotic abnormalities in metaphase I human spermatocytes from infertile males: frequencies, chromosomes involved, and the relationships with polymorphic karyotype and seminal parameters.

Authors:  Zaida Sarrate; Francesca Vidal; Joan Blanco
Journal:  Asian J Androl       Date:  2014 Nov-Dec       Impact factor: 3.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.